Breaking News

Bristol Myers Squibb Implements Veeva Vault CTMS

Streamlines trial management to speed medicines to patients.

Author Image

By: Charlie Sternberg

Associate Editor

Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management.   The new CTMS replaced a heritage Celgene CTMS and a heritage Bristol Myers Squibb CTMS and is tightly integrated with Veeva’s eTMF and Study Startup applications. The total implementation time was less than 20 months.   By launching Veeva’s trial management and monitoring solution companywide, Bristol Myers Squibb has established unified, agile, and simple trial processes aimed at making cl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters